Staar Surgical price target lowered to $57 from $71 at Stephens

Stephens analyst George Sellers lowered the firm’s price target on Staar Surgical to $57 from $71 and keeps an Overweight rating on the shares. While the quarterly results beat expectations, the company’s reduced guidance for 2023 was greater than anticipated, the analyst tells investors. However, Stephens remains confident in the company’s long-term opportunity.